RT

Rupinder Tewari

Active Director Director DIN 07009485
DIN 07009485 First appointment Dec 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Dec 2014
Shareholding value •••• Premium profile

About Rupinder Tewari

Data last updated:

Rupinder Tewari is a Director at Nectar Life Sciences Limited (since 2019), Director at Nectar Life Sciences Limited (since 2019) and Director at Nureca Limited (since 2025). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹3,472 Cr; the largest is Nectar Life Sciences Limited at ₹1,675 Cr (FY 2025). Earlier, Rupinder Tewari was a Director at Venus Remedies Limited (2014–2019).

DIN 07009485
Primary Designation Director
Industry Pharma
First Appointment 30 Dec 2014
Oldest Company Age 31 yrs
Largest company Nectar Life Sciences Limited · ₹1,675 Cr (FY 2025)
Combined revenue ₹3,472 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nectar Life Sciences Limited L24232PB1995PLC016664
Director11 Feb 20191995₹1,675 Cr (FY 2025)Active
Nectar Life Sciences Limited L21000PB1995PLC016664
Director11 Feb 20191995₹1,675 Cr (FY 2025)Active
Nureca Limited L24304MH2016PLC320868
Director01 Jan 20252016₹122 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Venus Remedies Limited L24232CH1989PLC009705
Director30 Dec 20141989₹669 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nectar Life Sciences Limited
Nureca Limited
Nectar Life Sciences Limited
Venus Remedies Limited
Premium access

Shareholding and investment profile for Rupinder Tewari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupinder Tewari

Rupinder Tewari currently holds 3 directorships: Nectar Life Sciences Limited (Director, since 11 Feb 2019, revenue ₹1,675 Cr (FY 2025)); Nectar Life Sciences Limited (Director, since 11 Feb 2019, revenue ₹1,675 Cr (FY 2025)); Nureca Limited (Director, since 01 Jan 2025, revenue ₹122 Cr (FY 2025)).

Rupinder Tewari was first appointed on 30 Dec 2014 as Director at Venus Remedies Limited. The most recent appointment on record is 01 Jan 2025 at Nureca Limited.

The 3 current companies of Rupinder Tewari that report revenue have a combined latest revenue of ₹3,472 Cr: Nectar Life Sciences Limited ₹1,675 Cr (FY 2025); Nectar Life Sciences Limited ₹1,675 Cr (FY 2025); Nureca Limited ₹122 Cr (FY 2025).

Rupinder Tewari held 1 earlier board appointment: Venus Remedies Limited (Director, 30 Dec 2014 to 24 May 2019).

The current boards of Rupinder Tewari's companies include Indu Pal Kaur (Nectar Life Sciences Limited), Kuldip Kumar Bhasin (Nectar Life Sciences Limited), Sanjaymohan Singh Rawat (Nectar Life Sciences Limited), Sanjiv Goyal (Nectar Life Sciences Limited), Surulichamy Senthilkumar (Nectar Life Sciences Limited), Sushil Kapoor (Nectar Life Sciences Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available